Warning

Definition

Anaemia (Haemoglobin below normal range) and macrocytosis (MCV above normal range).

This guideline is also applicable to patients with macrocytosis with additional blood abnormalities (e.g. neutropenia, thrombocytopenia, monocytosis, or combinations of abnormalities).

Myelodysplasia (MDS)

The major diagnosis to be considered in patients with macrocytic anaemia which is not caused by B12/folate deficiency, thyroid disorders, or reticulocytosis, is myelodysplasia.  This is a clonal marrow disorder causing peripheral blood cytopenias (sometimes increased monocytes).  It generally requires a bone marrow test for confirmation of diagnosis.  Treatments are available and may include blood transfusion, erythropoietin, or other therapies.  Please note there are many subtypes of myelodysplasia ranging from a very benign disorder requiring no treatment, to an extremely serious disorder very close to acute myeloid leukaemia.  Much of the literature available on the internet concentrates on the more aggressive subtypes.

Who to refer, who not to refer, how to refer

Who to refer:

  • Macrocytic anaemia where all above investigations are normal
  • Macrocytic anaemia where anaemia persists despite adequate replacement/treatment as indicated above
  • Macrocytic anaemia where blood film suggests myelodysplasia
  • Macrocytic anaemia with increased reticulocyte count
  • In severe cases – generally haemoglobin <80g/l or where patient is markedly symptomatic (breathless, angina, tachycardia) – refer urgently via Sci Gateway Referral

How to refer:

SCI Gateway to the Department of Haematology BGH

Primary care management

Thyroid function tests

B12

Folic Acid

Reticulocytes

Direct Antiglobulin Test if reticulocytes elevated

Immunoglobulins and serum electrophoresis

Local service details

haematologyconsultants@borders.scot.nhs.uk

Editorial Information

Last reviewed: 08/07/2025

Next review date: 08/07/2027

Author(s): Charlotte Robertson.